The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 6,601–6,700 of 31,469
Ellerbrock, J., Spaanderman, B., van Drongelen, J., Mulder, E., van Balen, V. A. L., Schiffer, V. M. M. M., Jorissen, L. M., Alers, R., Leenen, J., Ghossein‐Doha, C., et al. (2022) · Nutrients · doi:10.3390/nu14122444 · Cited by 68
Lee, J., Park, K., Lee, H. S., Park, H.-K., Han, J. H., & Ahn, S. B. (2022) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0099 · Cited by 54
Bai, J., Ma, Y., Zhao, Y., Yang, D., Mubarik, S., & Yu, C. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.158218 · Cited by 55
Angelidi, A. M., Kokkinos, A. D., Sanoudou, D., Connelly, M. A., Alexandrou, A. P., Mingrone, G., & Mantzoros, C. S. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155346 · Cited by 60
Wu, P., Wang, Y., Ye, Y., Yang, X., Huang, Y., Ye, Y., Lai, Y., Ouyang, J., Wu, L., Xu, J., et al. (2023) · BMC Medicine · doi:10.1186/s12916-023-02818-6 · Cited by 61
Plourde, C., Grenier–Larouche, T., Caron‐Dorval, D., Biron, S., Marceau, S., Lebel, S., Biertho, L. D., Tchernof, A., Richard, D., & Carpentier, A. C. (2014) · Obesity · doi:10.1002/oby.20771 · Cited by 55
Burden of chronic kidney disease in resource-limited settings from Peru: a population-based study
Francis, E. R., Kuo, C., Bernabé‐Ortiz, A., Nessel, L. C., Gilman, R. H., Checkley, W., Miranda, J. J., Feldman, H. I., & CRONICAS Cohort Study Group (2015) · BMC Nephrology · doi:10.1186/s12882-015-0104-7 · Cited by 54
Bel‐Serrat, S., Mouratidou, T., Jiménez‐Pavón, D., Huybrechts, I., Cuenca‐García, M., Mistura, L., Gottrand, F., González‐Gross, M., Dallongeville, J., Kafatos, A., et al. (2013) · Pediatric Obesity · doi:10.1111/j.2047-6310.2013.00187.x · Cited by 53
Xu, H., Guan, J., Yi, H., Zou, J., Meng, L., Tang, X., Zhu, H., Yu, D., Zhou, H., Su, K., et al. (2015) · Sleep And Breathing · doi:10.1007/s11325-015-1262-3 · Cited by 54
Obstetric and metabolic implications of excessive gestational weight gain in pregnancy
Walsh, J., McGowan, C. A., Mahony, R. M., Foley, M. E., & McAuliffe, F. M. (2014) · Obesity · doi:10.1002/oby.20753 · Cited by 57
Collison, K. S., Maqbool, Z. M., Inglis, A. L., Makhoul, N. J., Saleh, S. M., Bakheet, R., Al‐Johi, M. A., Al‐Rabiah, R. K., Zaidi, M. Z., & Al-Mohanna, F. A. (2010) · Obesity · doi:10.1038/oby.2009.502 · Cited by 54
Lin, C., Kardia, S. L. R., Li, C., Liu, C.-S., Lai, M.-M., Lin, C., Chang, P.-C., Lee, Y., Chen, C., Lin, C., et al. (2010) · BMC Public Health · doi:10.1186/1471-2458-10-579 · Cited by 55
Strazzullo, P., Barbato, A., Siani, A., Cappuccio, F. P., Versiero, M., Schiattarella, P., Russo, O., Avallone, S., Valle, E. D., & Farinaro, E. (2008) · Metabolism · doi:10.1016/j.metabol.2007.10.010 · Cited by 56
Chujo, D., Yagi, K., Asano, A., Muramoto, H., SAKAI, S., Ohnishi, A., Shintaku-Kubota, M., Mabuchi, H., Yamagishi, M., & Kobayashi, J. (2007) · Hypertension Research · doi:10.1291/hypres.30.1205 · Cited by 53
Mohamadin, A. M., Habib, F., & Elahi, T. F. (2009) · Pathophysiology · doi:10.1016/j.pathophys.2009.11.004 · Cited by 54
Otaki, Y., Watanabe, T., Takahashi, H., Hirayama, A., Narumi, T., Kadowaki, S., Honda, Y., Arimoto, T., Shishido, T., Miyamoto, T., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094834 · Cited by 55
Kashiwagi, A., Shiga, T., Akiyama, N., Kazuta, K., Utsuno, A., Yoshida, S., & Ueyama, E. (2014) · Diabetology International · doi:10.1007/s13340-014-0182-y · Cited by 55
Sasang constitutional types can act as a risk factor for insulin resistance
Choi, K.-J., Lee, J., Yoo, J.-H., Lee, E., Koh, B., & Lee, J. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.11.017 · Cited by 54
Effect of a hypocaloric diet on serum visfatin in obese non-diabetic patients
de Luis, D. A., Sagrado, M. G., Conde, R., Aller, R., Izaola, O., & Romero, E. (2008) · Nutrition · doi:10.1016/j.nut.2008.01.052 · Cited by 54
Bao, Y., Lu, Z., Zhou, M., Li, H., Wang, Y., Gao, M., Wei, M., & Jia, W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019115 · Cited by 53
Esteghamati, A., Aryan, Z., Esteghamati, A., & Nakhjavani, M. (2014) · Diabetes & Metabolism · doi:10.1016/j.diabet.2014.02.007 · Cited by 55
Lallukka, S., Sevastianova, K., Perttilä, J., Hakkarainen, A., Orho‐Melander, M., Lundbom, N. M. I., Olkkonen, V. M., & Yki-Järvinen, H. (2013) · Diabetologia · doi:10.1007/s00125-013-2829-9 · Cited by 54
Florakis, D., Diamanti‐Kandarakis, E., Katsikis, I., Nassis, G. P., Karkanaki, A., Georgopoulos, N. A., & Panidis, D. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803777 · Cited by 53
Correlates of low testosterone in men with chronic spinal cord injury
Barbonetti, A., Vassallo, M. R. C., Pacca, F., Cavallo, F., Costanzo, M., Felzani, G., Francavilla, S., & Francavilla, F. (2014) · Andrology · doi:10.1111/j.2047-2927.2014.00235.x · Cited by 55
Burgdorf, K. S., Grarup, N., Justesen, J. M., Harder, M. N., Witte, D. R., Jørgensen, T., Sandbæk, A., Lauritzen, T., Madsbad, S., Hansen, T. F., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015813 · Cited by 55
Martin, R. M., Holly, J. M. P., Smith, G. D., & Gunnell, D. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0745 · Cited by 54
Kostapanos, M. S., Milionis, H. J., Agouridis, A. P., Rizos, C. V., & Elisaf, M. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02101.x · Cited by 54
Ükinç, K., Eminağaoğlu, S., Ersöz, H. Ö., Erem, C., Karahan, C., Hacıhasanoğlu, A., & Koçak, M. (2009) · Endocrine · doi:10.1007/s12020-009-9236-5 · Cited by 54
Effects of growth hormone treatment in adults with Prader–Willi syndrome
Butler, M. G., SMITH, B. K., Lee, J., et al. (2013) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2013.01.001 · Cited by 54
Endometrial Shedding Effect on Conception and Live Birth in Women With Polycystic Ovary Syndrome
Diamond, M. P., Kruger, M., Santoro, N. F., Zhang, H., Casson, P. R., Schlaff, W. D., Coutifaris, C., Brzyski, R. G., Christman, G. M., Carr, B. R., et al. (2012) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e31824da35c · Cited by 54
Point: HOMA—Satisfactory for the Time Being
McAuley, K. A., Mann, J. I., Chase, J. G., Lotz, T., & Shaw, G. M. (2007) · Diabetes Care · doi:10.2337/dc07-1067 · Cited by 55
Estimated GFR Is Biased by Non-Traditional Cardiovascular Risk Factors
Melsom, T., Fuskevåg, O., Mathisen, U. D., Strand, H., Schei, J., Jenssen, T. G., Solbu, M. D., & Eriksen, B. O. (2015) · American Journal of Nephrology · doi:10.1159/000371557 · Cited by 56
Ferreira, T. D. S., Klein, M. R. S. T., & Sanjuliani, A. F. (2013) · British Journal Of Nutrition · doi:10.1017/s0007114513000111 · Cited by 51
Intermittent versus on‐demand use of a very low calorie diet: a randomized 2‐year clinical trial
Lantz, H., Peltonen, M., Ågren, L., & Torgerson, J. (2003) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01131.x · Cited by 54
Martins, W. P., Santana, L. F., Nastri, C. O., Ferriani, F. A., de Sá, M. F. S., & dos Reis, R. M. (2007) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2006.10.038 · Cited by 54
Mohammadzadeh, G., & Zarghami, N. (2009) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365510903137237 · Cited by 57
Coronary Artery Calcification and Family History of Myocardial Infarction in the Dallas Heart Study
Paixao, A. R. M., Berry, J. D., Neeland, I. J., Ayers, C. R., Rohatgi, A. K., de Lemos, J. A., & Khera, A. (2014) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2014.04.004 · Cited by 54
Bovet, P., Romain, S., Shamlaye, C. F., Mendis, S., Darioli, R., Riesen, W., Tappy, L., & Paccaud, F. M. (2009) · Cardiovascular Diabetology · doi:10.1186/1475-2840-8-34 · Cited by 56
Insulin Resistance Indices Are Inversely Associated With Vitamin D Binding Protein Concentrations
Ashraf, A. P., Huisingh, C., Alvarez, J. A., Wang, X., & Gower, B. A. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2452 · Cited by 54
Krššák, M., Hofer, H., Wrba, F., Meyerspeer, M., Brehm, A., Lohninger, A., Steindl‐Munda, P., Moser, E., Ferenci, P., & Roden, M. (2009) · European Journal of Radiology · doi:10.1016/j.ejrad.2009.03.062 · Cited by 54
Hadimioğlu, N., Ulugöl, H., Akbas, H. S., Coşkunfırat, N., Ertuğ, Z., & Dinçkan, A. (2012) · Transplantation Proceedings · doi:10.1016/j.transproceed.2012.08.004 · Cited by 54
Indicadores antropométricos de resistência à insulina
Vasques, A. C. J., Rosado, L. E. F. P. D. L., Rosado, G. P., Ribeiro, R. D. C. L., Franceschini, S. D. C. C., & Geloneze, B. (2010) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2010001100025 · Cited by 66
Ricci, G., Bersani, G., Rossi, A., Pigò, F., Fabritiis, G. D., & Alvisi, V. (2008) · Obesity Surgery · doi:10.1007/s11695-008-9487-x · Cited by 53
Fasting Plasma Leptin Level Is a Surrogate Measure of Insulin Sensitivity
Askari, H., Tykodi, G., Liu, J., & Dagogo-Jack, S. E. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0296 · Cited by 54
Increased visfatin and leptin in pregnancies complicated by pre-eclampsia
Adalı, E., Yıldızhan, R., Kolusarı, A., Kurdoğlu, M., Buğdaycı, G., Şahin, H. G., & Kamacı, M. (2009) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767050902994622 · Cited by 54
Arnaíz, P., Mónica Acevedo, B., Salesa Barja, Y., Marlene Aglony, I., Guzmán, B., Cassis, B., Carvajal, J., Moreno, M., Navarrete, C., & Berrios, X. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.08.007 · Cited by 54
Antidiabetic Effect ofMorinda citrifolia(Noni) Fermented byCheonggukjangin KK-AyDiabetic Mice
Lee, S., Park, S., Hwang, J., Yi, S.-H., Nam, Y., & Lim, S. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/163280 · Cited by 58
Papathanassiou, K., Naka, K. Κ., Kazakos, N., Kanioglou, C., Makriyiannis, D., Pappas, K. D., Katsouras, C. S., Liveris, K., Kolettis, T. M., Tsatsoulis, A. A., et al. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.11.027 · Cited by 53
Qatanani, M., Tan, Y., Dobrin, R., Greenawalt, D. M., Hu, G., Zhao, W., Olefsky, J. M., Sears, D. D., Kaplan, L. M., & Kemp, D. M. (2012) · Diabetes · doi:10.2337/db12-0399 · Cited by 54
Choi, K. M., Yannakoulia, M., Park, M. S., Cho, G. J., Kim, J. H., Lee, S. H., Hwang, T. G., Yang, S. J., Kim, T. N., Yoo, H. J., et al. (2010) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.29667 · Cited by 54
Vaidya, A., Forman, J. P., UNDERWOOD, P. C., Hopkins, P. N., Williams, G. H., Pojoga, L. H., & Williams, J. S. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0025 · Cited by 54
Chen, L., Lin, M.-H., Chen, Z.-J., Hwang, S., & Chiou, S.-T. (2006) · Journal of the Chinese Medical Association · doi:10.1016/s1726-4901(09)70251-5 · Cited by 54
Kanaya, A. M., Santoyo‐Olsson, J., Gregorich, S. E., Grossman, M. D., Moore, T., & Stewart, A. L. (2012) · American Journal of Public Health · doi:10.2105/ajph.2011.300456 · Cited by 57
Beardsall, K., Ong, K. K., Murphy, N., Ahmed, M. L., Zhao, J. H., Peeters, M., & Dunger, D. B. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0757 · Cited by 54
Post‐partum weight loss and glucose metabolism in women with gestational diabetes: the DEBI Study
Ehrlich, S. F., Hedderson, M. M., Quesenberry, C. P., Feng, J., Brown, S. D., Crites, Y., & Ferrara, A. M. (2014) · Diabetic Medicine · doi:10.1111/dme.12425 · Cited by 58
Kim, J., Mun, H.-S., Lee, B. K., Yoon, S. B., Choi, E., Min, P., Yoon, Y. W., Hong, B., Rim, S., & Kwon, H. M. (2010) · Yonsei Medical Journal · doi:10.3349/ymj.2010.51.5.676 · Cited by 54
Colao, A. A. L., Auriemma, R. S., Galdiero, M., Cappabianca, P., Cavallo, L. M., Esposito, F., Grasso, L. F. S., Lombardi, G., & Pivonello, R. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1546 · Cited by 55
Total and High-Molecular-Weight Adiponectin and Risk of Incident Diabetes in Older People
Kizer, J. R., Arnold, A. M., Benkeser, D. C., Ix, J. H., Djoussé, L., Zieman, S. J., Barzilay, J. I., Tracy, R. P., Mantzoros, C. S., Siscovick, D. S., et al. (2011) · Diabetes Care · doi:10.2337/dc11-1519 · Cited by 54
Palou, M., Priego, T., Sánchez, J., Torrens, J. M., Palou, A., & Picó, C. (2010) · Endocrinology · doi:10.1210/en.2009-0934 · Cited by 57
Chappuis, B., Braun, M., Stettler, C., Allemann, S., Diem, P., Lumb, P. J., Wierzbicki, A. S., James, R. W., & Christ, E. (2007) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.715 · Cited by 54
The metabolic syndrome in early pregnancy and risk of gestational diabetes mellitus
Chatzi, L., Plana, E., Pappas, A. C., Alegkakis, D., Karakosta, P., Daraki, V. N., Vassilaki, M. E., Tsatsanis, C., Kafatos, A., Koutis, A. D., et al. (2009) · Diabetes & Metabolism · doi:10.1016/j.diabet.2009.07.003 · Cited by 52
Insulin Resistance and Risk of Cardiovascular Disease in Postmenopausal Women
Schmiegelow, M., Hedlin, H., Stefanick, M. L., Mackey, R. H., Allison, M., Martin, L. W., Robinson, J. G., & Hlatky, M. A. (2015) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.114.001563 · Cited by 56
Blé‐Castillo, J. L., Aparicio-Trápala, M. A., Juárez‐Rojop, I. E., Torres‐López, J. E., Méndez, J. D., Aguilar-Mariscal, H., Olvera‐Hernández, V., Palma-Cordova, L. C., & Díaz-Zagoya, J. C. (2012) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph9051663 · Cited by 54
Heinzle, S., Ball, G. D. C., & Kuk, J. L. (2015) · Pediatric Obesity · doi:10.1111/ijpo.12083 · Cited by 54
Agostinis‐Sobrinho, C., Santos, R., Moreira, C. M. M., Abreu, S., Lopes, L., Oliveira‐Santos, J., Rosario, R. V., Póvoas, S. C. A., & Mota, J. A. P. S. (2016) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2016.02.011 · Cited by 53
Sanches, J. R., França, L. M., Chagas, V. T., Gaspar, R. S., dos Santos, K. A., Gonçalves, L. M., Sloboda, D. M., Holloway, A. C., Dutra, R. P., Carneiro, E. M., et al. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00048 · Cited by 56
Manjunatha, S., Vempati, R. P., Ghosh, D., & Bijlani, R. L. (2005) · PubMed · Cited by 54
Liu, C.-T., Raghavan, S., Maruthur, N. M., Kabagambe, E. K., Hong, J., Ng, M. C. Y., Hivert, M., Lu, Y., An, P., Bentley, A. R., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.05.006 · Cited by 56
Kelstrup, L., Hjort, L., Houshmand‐Oeregaard, A. S., Clausen, T. D., Hansen, N. S., Broholm, C., Borch‐Johnsen, L., Mathiesen, E. R., Vaag, A. A., & Damm, P. (2016) · Diabetes · doi:10.2337/db16-0227 · Cited by 57
Thomas, A. P., Hoang, J. D., Vongbunyong, K. E., Nguyen, A., Rakshit, K., & Matveyenko, A. V. (2016) · Endocrinology · doi:10.1210/en.2016-1309 · Cited by 54
Insulin Sensitivity and Carotid Intima-Media Thickness
Kozàkovà, M., Natali, A., Dekker, J., Beck‐Nielsen, H., Laakso, M., Nilsson, P. M., Balkau, B., & Ferrannini, E. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300948 · Cited by 54
Khoudary, S. R. E., Shields, K. J., Janssen, İ., Budoff, M. J., Everson‐Rose, S. A., Powell, L. H., & Matthews, K. A. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.004545 · Cited by 54
Effects of Moringa oleifera aqueous leaf extract in alloxan induced diabetic mice
Tuorkey, M. J. (2016) · Interventional Medicine and Applied Science · doi:10.1556/1646.8.2016.3.7 · Cited by 55
Shim, Y. S., Kang, M. J., Oh, Y. J., Baek, J. W., Yang, S., & Hwang, I. T. (2017) · Medicine · doi:10.1097/md.0000000000006179 · Cited by 56
Picu, A. A., Petcu, L. M., Ștefan, S., Mitu, M., Lixandru, D., Ionescu-Tirgoviste, C., Pîrcălăbioru, G. G., Ciulu-Costinescu, F., Bubulică, M.-V., & Chifiriuc, M. C. (2017) · Molecules · doi:10.3390/molecules22050714 · Cited by 54
Evans, R. A., Frese, M., Romero, J., Cunningham, J. H., & Mills, K. (2017) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.145169 · Cited by 58
Lima, L. G., Bonardi, J. M. T., Campos, G. O., Bertani, R. F., Scher, L. M. D. L., Moriguti, J. C., Ferriolli, E., & Lima, N. K. C. (2017) · Clinics · doi:10.6061/clinics/2017(06)06 · Cited by 58
Robinson, M. M., Lowe, V. J., & Nair, K. S. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01571 · Cited by 57
Chueakula, N., Jaikumkao, K., Arjinajarn, P., Pongchaidecha, A., Chatsudthipong, V., Chattipakorn, N., & Lungkaphin, A. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.11.021 · Cited by 54
Natriuretic peptides promote glucose uptake in a cGMP-dependent manner in human adipocytes
Coué, M., Barquissau, V., Morigny, P., Louche, K., Lefort, C., Mairal, A., Carpéné, C., Viguerie, N., Arner, P., Langin, D., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-19619-0 · Cited by 53
Liu, J., Duan, Y., Fu, J. H., & Wang, G. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00130 · Cited by 54
Jin, H. Y. (2018) · Journal of Paediatrics and Child Health · doi:10.1111/jpc.13926 · Cited by 54
Tg/Hdl-C Ratio as Cardio-Metabolic Biomarker even in Normal Weight Women
Borrayo, G. (2018) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2018.261 · Cited by 54
Okura, T., Nakamura, R., Fujioka, Y., Kawamoto-Kitao, S., Ito, Y., Matsumoto, K., Shoji, K., Sumi, K., Matsuzawa, K., Izawa, S., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201052 · Cited by 55
Torres‐Castillo, N., Silva-Gómez, J. A., Campos-Perez, W. Y., Barrón‐Cabrera, E., Hernández‐Cañaveral, I., Garcı́a-Cazarı́n, M. L., Márquez‐Sandoval, F., González‐Becerra, K., Barrón-Gallardo, C. A., & Martínez‐López, E. (2018) · Obesity Facts · doi:10.1159/000492116 · Cited by 54
Malik, V., Sudha, V., Wedick, N. M., RamyaBai, M., Vijayalakshmi, P., Lakshmipriya, N., Gayathri, R., Kokila, A., Jones, C. Y., Hong, B., et al. (2019) · British Journal Of Nutrition · doi:10.1017/s000711451900076x · Cited by 57
Hess, A. L., Benítez‐Páez, A., Blædel, T., Larsen, L. H., Iglesias, J. R., Madera, C., Sanz, Y., & Larsen, T. M. (2019) · European Journal of Nutrition · doi:10.1007/s00394-019-02099-x · Cited by 54
Tamer, F., Uluğ, E., Akyol, A., & Nergiz‐Unal, R. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.110914 · Cited by 55
Kobyliak, N. M., Falalyeyeva, T. M., Mykhalchyshyn, G., Molochek, N., Savchuk, О., Kyriienko, D., & Komisarenko, I. (2020) · Obesity Medicine · doi:10.1016/j.obmed.2020.100248 · Cited by 54
Guagnano, M. T., D’Angelo, C., Caniglia, D., Giovanni, P. D., Celletti, E., Sabatini, E., Speranza, L., Bucci, M., Cipollone, F., & Paganelli, R. (2021) · Nutrients · doi:10.3390/nu13103535 · Cited by 54
Active Brown Adipose Tissue Is Associated With a Healthier Metabolic Phenotype in Obesity
Herz, C. T., Kulterer, O. C., Prager, M., Schmöltzer, C., Langer, F. B., Prager, G., Marculescu, R., Kautzky‐Willer, A., Hacker, M., Haug, A. R., et al. (2021) · Diabetes · doi:10.2337/db21-0475 · Cited by 62
Mager, D. R., Wykes, L., Roberts, E. A., Ball, R. O., & Pencharz, P. B. (2006) · Journal of Nutrition · doi:10.1093/jn/136.1.133 · Cited by 55
Pontiroli, A. E., Pizzocri, P., Saibene, A., Girola, A., Koprivec, D., & Fragasso, G. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802733 · Cited by 54
Oxidative Stress and Adverse Adipokine Profile Characterize the Metabolic Syndrome in Children
Kelly, A. S., Steinberger, J., Kaiser, D. R., Olson, T. P., Bank, A. J., & Dengel, D. R. (2006) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.1559-4564.2006.05758.x · Cited by 54
Undén, A., Elofsson, S., & Brismar, K. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02306.x · Cited by 54
Insulin resistance and HCV: Will new knowledge modify clinical management?
Negro, F. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.07.011 · Cited by 54
Jenkins, D. J. A., Kendall, C. W. C., Marchie, A., Josse, A. R., Nguyen, T. H., Faulkner, D. A., Lapsley, K. G., & Singer, W. (2008) · Metabolism · doi:10.1016/j.metabol.2008.01.032 · Cited by 54
Cheung, M. C., Brown, B. G., Larsen, E. K. M., Frutkin, A. D., O’Brien, K. D., & Albers, J. J. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2005.09.002 · Cited by 56
Carey, V. J., Bishop, L. M., Charleston, J. B., Conlin, P. R., Erlinger, T. P., Laranjo, N., McCarron, P. B., Miller, E. R., ROSNER, B. A., Swain, J., et al. (2005) · Clinical Trials · doi:10.1191/1740774505cn123oa · Cited by 54
ACDC/Adiponectin and PPAR‐γ Gene Polymorphisms: Implications for Features of Obesity
Tankó, L. B., Siddiq, A., Lecœur, C., Larsen, P. J., Christiansen, C., Walley, A. J., & Froguel, P. (2005) · Obesity Research · doi:10.1038/oby.2005.262 · Cited by 54
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
